Opinion

Video

Patient Selection and Switching Patients to Subcutaneous Infliximab

Author(s):

Jean-Frederic Colombel, MD

Jean-Frederic Colombel, MD, examines considerations for transitioning patients from intravenous to subcutaneous infliximab and evaluates the role of subcutaneous infliximab within the evolving landscape of inflammatory bowel disease treatments.

  1. For patients currently receiving IV infliximab (originator or biosimilar), are there any considerations for switching them to subcutaneous infliximab?
  2. How will subcutaneous infliximab fit in with the growing IBD treatment landscape?
Related Videos
How to Manage Aspirin-Exacerbated Respiratory Disease
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
AMG0001 Advances Healing in CLTI with David G. Armstrong, DPM, PhD, and Michael S. Conte, MD | Image Credit: Canva
4 experts are featured in this series.
4 experts are featured in this series.
Malin Fromme, MD | Credit: RWTH Aachen
Related Content
Anaphylm Sublingual Film for Anaphylaxis Receives Positive FDA Feedback | Image Credit: US Food and Drug Administration
December 2nd 2024

Anaphylm Sublingual Film for Anaphylaxis Receives Positive FDA Feedback

Connor Iapoce
Medical Ethics Unpacked: Ethical Considerations for Euthanasia and Medically-Assisted Suicide
November 22nd 2024

Medical Ethics Unpacked: Ethical Considerations for Euthanasia & Medical Assistance in Dying

Steven Levine, MD Dominic Sisti, PhD
FDA Clears Initiation of Phase 2 Efficacy Trial for Ruxoprubart in IgAN| Image Credit: US Food and Drug Administration
December 2nd 2024

FDA Clears Initiation of Phase 2 Efficacy Trial for Ruxoprubart in IgAN

Connor Iapoce
Medical Ethics Unpacked:
November 22nd 2024

Medical Ethics Unpacked: Ethical Foundations and Background of Euthanasia & Medically-Assisted Suicide

Steven Levine, MD Dominic Sisti, PhD
HCPLive Endocrinology Month in Review: November 2024
December 1st 2024

Endocrinology Month in Review: November 2024

Patrick Campbell
HCPLive Cardiology Month in Review: November 2024
December 1st 2024

Cardiology Month in Review: November 2024

Patrick Campbell Connor Iapoce
© 2024 MJH Life Sciences

All rights reserved.